A United Kingdom supplier, with 1 awarded contract, totalling £1.3m, most recently 8 months ago.
This is a framework agreement for the supply of pharmaceuticals. Due to space limitations, detailed descriptions and quantities related to the framework agreement and subsequent contracts are specified in the Terms of Reference and the list of lots included in this documentation, excluding VAT. The
This contract involves the procurement of medicines across 169 lots. Detailed descriptions and quantities can be found in the specifications document, as this field does not allow for the inclusion of all information. Suppliers have 19 days to request clarifications before the deadline for submittin
This is a tender for various pharmaceutical products, divided into lots, as specified in the terms of reference. The contracting authority will respond clearly and completely to all requests for clarification within 10 days before the deadline set in the participation announcement for submitting off
This is a public procurement framework agreement for antineoplastic drugs, divided into 60 lots, intended for a duration of 36 months. Suppliers are invited to submit their offers based on the specifications provided in the tender documents. Please note that, according to the provisions of O.U.G. 10
This procurement opportunity involves the acquisition of various medicines, divided into 304 lots. The contracting authority will purchase a range of medications as specified in the procurement documents. The estimated value of the largest subsequent contract is detailed in section 3 of the specific
